Walgreens Boots Alliance reported a decrease in earnings per share to 33 cents in the fiscal third quarter, compared with $1.38 in the year-ago quarter. Adjusted earnings per share came in at 96 cents, surpassing analysts’ expectations of 92 cents per share.
The pharmacy retail company’s sales from continuing operations decreased -4.2 percent from the year-ago quarter to $32.6 billion. The company reported a $683 million charge related to its opioid settlement with the State of Florida in the current quarter.
In the U.K., Boots’ comparable sales climbed +24 percent, indicating some recovery in footfall, although store footfall remains around 20 percent below pre-Covid levels.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
a provider of drug store services
Industry DrugstoreChains